Log in to save to my catalogue

Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response

Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8debd2644ced4e2d948948cd2bf86a07

Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response

About this item

Full title

Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2020-02, Vol.11 (1), p.1110-14, Article 1110

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Targeted delivery of a nanovaccine loaded with a tumor antigen and adjuvant to the lymph nodes (LNs) is an attractive approach for improving cancer immunotherapy outcomes. However, the application of this technique is restricted by the paucity of suitable tumor-associated antigens (TAAs) and the sophisticated technology required to identify tumor n...

Alternative Titles

Full title

Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8debd2644ced4e2d948948cd2bf86a07

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8debd2644ced4e2d948948cd2bf86a07

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-020-14906-9

How to access this item